{"id":"https://openalex.org/W3098257960","doi":null,"title":"Chronic Nonclinical Ocular Toxicity Study of KSI-301 Demonstrates Tolerability after Intravitreal Administration in Cynomolgus Monkeys","display_name":"Chronic Nonclinical Ocular Toxicity Study of KSI-301 Demonstrates Tolerability after Intravitreal Administration in Cynomolgus Monkeys","publication_year":2019,"publication_date":"2019-07-22","ids":{"openalex":"https://openalex.org/W3098257960","mag":"3098257960"},"language":"en","primary_location":{"id":"mag:3098257960","doi":null,"is_oa":true,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2740837","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://iovs.arvojournals.org/article.aspx?articleid=2740837","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"John G. Sinclair","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John G. Sinclair","raw_affiliation_strings":["Kodiak Sciences Inc., Palo Alto, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kodiak Sciences Inc., Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hong Liang","orcid":"https://orcid.org/0000-0002-0579-8651","observed_orcids":["https://orcid.org/0000-0002-0579-8651"]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hong Liang","raw_affiliation_strings":["Kodiak Sciences Inc., Palo Alto, California, United States"],"raw_orcid":"https://orcid.org/0000-0002-0579-8651","affiliations":[{"raw_affiliation_string":"Kodiak Sciences Inc., Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108274014","display_name":"zachary antonio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60638368","display_name":"Covance (United States)","ror":"https://ror.org/02hhsqf45","country_code":"US","type":"company","lineage":["https://openalex.org/I60638368"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"zachary antonio","raw_affiliation_strings":["Covance Laboratories Inc., Wisconsin, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covance Laboratories Inc., Wisconsin, United States","institution_ids":["https://openalex.org/I60638368"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103005571","display_name":"Paul E. Miller","orcid":"https://orcid.org/0000-0002-6201-5035","observed_orcids":["https://orcid.org/0000-0002-6201-5035"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul E. Miller","raw_affiliation_strings":["OSOD, LLC, Wisconsin, United States"],"raw_orcid":"https://orcid.org/0000-0002-6201-5035","affiliations":[{"raw_affiliation_string":"OSOD, LLC, Wisconsin, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037625942","display_name":"avery tolosa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"avery tolosa","raw_affiliation_strings":["Kodiak Sciences Inc., Palo Alto, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kodiak Sciences Inc., Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039029185","display_name":"Joel Naor","orcid":"https://orcid.org/0000-0002-3883-7688","observed_orcids":["https://orcid.org/0000-0002-3883-7688"]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel Naor","raw_affiliation_strings":["Kodiak Sciences Inc., Palo Alto, California, United States"],"raw_orcid":"https://orcid.org/0000-0002-3883-7688","affiliations":[{"raw_affiliation_string":"Kodiak Sciences Inc., Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009143659","display_name":"leah quarberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60638368","display_name":"Covance (United States)","ror":"https://ror.org/02hhsqf45","country_code":"US","type":"company","lineage":["https://openalex.org/I60638368"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"leah quarberg","raw_affiliation_strings":["Covance Laboratories Inc., Wisconsin, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covance Laboratories Inc., Wisconsin, United States","institution_ids":["https://openalex.org/I60638368"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007855596","display_name":"Alok K Sharma","orcid":"https://orcid.org/0000-0001-7014-4753","observed_orcids":["https://orcid.org/0000-0001-7014-4753"]},"institutions":[{"id":"https://openalex.org/I60638368","display_name":"Covance (United States)","ror":"https://ror.org/02hhsqf45","country_code":"US","type":"company","lineage":["https://openalex.org/I60638368"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alok Sharma","raw_affiliation_strings":["Covance Laboratories Inc., Wisconsin, United States"],"raw_orcid":"https://orcid.org/0000-0001-7014-4753","affiliations":[{"raw_affiliation_string":"Covance Laboratories Inc., Wisconsin, United States","institution_ids":["https://openalex.org/I60638368"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026405111","display_name":"Xiaojian Huang","orcid":"https://orcid.org/0000-0003-0047-6343","observed_orcids":["https://orcid.org/0000-0003-0047-6343"]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaojian Huang","raw_affiliation_strings":["Kodiak Sciences Inc., Palo Alto, California, United States"],"raw_orcid":"https://orcid.org/0000-0003-0047-6343","affiliations":[{"raw_affiliation_string":"Kodiak Sciences Inc., Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069370990","display_name":"Janine Lu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janine Lu","raw_affiliation_strings":["Kodiak Sciences Inc., Palo Alto, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kodiak Sciences Inc., Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040117245","display_name":"William Ngo","orcid":"https://orcid.org/0000-0003-3324-1065","observed_orcids":["https://orcid.org/0000-0003-3324-1065"]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Ngo","raw_affiliation_strings":["Kodiak Sciences Inc., Palo Alto, California, United States"],"raw_orcid":"https://orcid.org/0000-0003-3324-1065","affiliations":[{"raw_affiliation_string":"Kodiak Sciences Inc., Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087550308","display_name":"Dan Dang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan Dang","raw_affiliation_strings":["Kodiak Sciences Inc., Palo Alto, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kodiak Sciences Inc., Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010821938","display_name":"Frances A. S. Clemo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60638368","display_name":"Covance (United States)","ror":"https://ror.org/02hhsqf45","country_code":"US","type":"company","lineage":["https://openalex.org/I60638368"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. A. S. Clemo","raw_affiliation_strings":["Covance Laboratories Inc., Wisconsin, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covance Laboratories Inc., Wisconsin, United States","institution_ids":["https://openalex.org/I60638368"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036172456","display_name":"James N. Ver Hoeve","orcid":"https://orcid.org/0000-0003-3541-7589","observed_orcids":["https://orcid.org/0000-0003-3541-7589"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James N. Ver Hoeve","raw_affiliation_strings":["OSOD, LLC, Wisconsin, United States"],"raw_orcid":"https://orcid.org/0000-0003-3541-7589","affiliations":[{"raw_affiliation_string":"OSOD, LLC, Wisconsin, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072222944","display_name":"T. Michael Nork","orcid":"https://orcid.org/0000-0002-0687-373X","observed_orcids":["https://orcid.org/0000-0002-0687-373X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Michael Nork","raw_affiliation_strings":["OSOD, LLC, Wisconsin, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSOD, LLC, Wisconsin, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049870230","display_name":"D. Victor Perlroth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387154517","display_name":"Kodiak Sciences","ror":"https://ror.org/01cgrd369","country_code":"US","type":"company","lineage":["https://openalex.org/I4387154517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Victor Perlroth","raw_affiliation_strings":["Kodiak Sciences Inc., Palo Alto, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kodiak Sciences Inc., Palo Alto, California, United States","institution_ids":["https://openalex.org/I4387154517"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1850,"currency":"USD","value_usd":1850},"apc_paid":{"value":1850,"currency":"USD","value_usd":1850},"fwci":0.2416,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.60804407,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"60","issue":"9","first_page":"126","last_page":"126"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.336899995803833,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.02759999968111515,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intravitreal-administration","display_name":"intravitreal administration","score":0.6019999980926514},{"id":"https://openalex.org/keywords/ocular-toxicity","display_name":"ocular toxicity","score":0.8679999709129333},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7210000157356262},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.9020000100135803},{"id":"https://openalex.org/keywords/chronic-toxicity","display_name":"chronic toxicity","score":0.7210000157356262},{"id":"https://openalex.org/keywords/ocular-drug-delivery","display_name":"ocular drug delivery","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8415223360061646},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6519333124160767},{"id":"https://openalex.org/C2779742858","wikidata":"https://www.wikidata.org/wiki/Q180609","display_name":"Intravitreal administration","level":3,"score":0.6025442481040955},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5462195873260498},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4362659752368927},{"id":"https://openalex.org/C2780765947","wikidata":"https://www.wikidata.org/wiki/Q12033531","display_name":"Administration (probate law)","level":2,"score":0.4208489954471588},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.3510929048061371},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1748155951499939},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.10501524806022644},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.0733327865600586},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.04435759782791138},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3098257960","doi":null,"is_oa":true,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2740837","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null}],"best_oa_location":{"id":"mag:3098257960","doi":null,"is_oa":true,"landing_page_url":"https://iovs.arvojournals.org/article.aspx?articleid=2740837","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1161403149","https://openalex.org/W2993727172","https://openalex.org/W1173408860","https://openalex.org/W2910274579","https://openalex.org/W2992766438","https://openalex.org/W2994358882","https://openalex.org/W1175035097","https://openalex.org/W2994568182","https://openalex.org/W1125720618","https://openalex.org/W2608524560"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2020-11-23T00:00:00"}